多発性硬化症:世界市場(医薬品市場予測及び分析~2022)...市場調査レポートについてご紹介

【英文タイトル】PharmaPoint: Multiple Sclerosis - Global Drug Forecast and Market Analysis to 2022 Event-Driven Update

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1 Table of Contents
1 Table of Contents 8
1.1 List of Tables 15
1.2 List of Figures 19
2 Introduction 21
2.1 Catalyst 21
2.2 Upcoming Related Reports 22
3 Disease Overview 23
3.1 Etiology and Pathophysiology 23
3.1.1 Etiology 23
3.1.2 Pathophysiology 24
3.1.3 Classification of Multiple Sclerosis 25
3.2 Symptoms 27
3.2.1 Prognosis 28
3.2.2 Quality of Life 29
4 Epidemiology 30
4.1 Risk Factors 30
4.1.1 Family members of MS patients have a 1-5% risk of developing MS 30
4.1.2 Women are twice as likely to develop MS, but men have a worse prognosis 30
4.1.3 Caucasians have a higher risk of MS than any other race/ethnicity 31
4.1.4 Protective effect of vitamin D on MS may relate to latitude and month of birth 31
4.1.5 Timing of environmental exposures affects MS risk 32
4.1.6 Exposure to smoking may increase MS risk and worsen prognosis 32
4.2 Comorbidities 33
4.2.1 Autoimmune diseases may be comorbidities of MS 33
4.2.2 Mental comorbidities are found in up to 60% of MS patients and may affect relapse rates 34
4.3 Global Trends 35
4.3.1 North America 35
4.3.2 Europe 36
4.3.3 Asia 36
4.4 Forecast Methodology 37
4.4.1 Sources Used 39
4.4.2 Forecast Assumptions and Methods 45
4.4.3 Sources Not Used 54
4.5 Epidemiology Forecast for Multiple Sclerosis 55
4.5.1 Total Prevalent Cases of Multiple Sclerosis 55
4.5.2 Age-Specific Prevalent Cases of Multiple Sclerosis 57
4.5.3 Gender-Specific Prevalent Cases of Multiple Sclerosis 59
4.5.4 Total Incident Cases of Multiple Sclerosis 61
4.5.5 Age-Specific Incident Cases of Multiple Sclerosis 63
4.5.6 Gender-Specific Incident Cases of Multiple Sclerosis 65
4.5.7 Multiple Sclerosis Subtypes 67
4.6 Discussion 68
4.6.1 Conclusions on Epidemiological Trends 68
4.6.2 Limitations of the Analysis 69
4.6.3 Strengths of the Analysis 69
5 Disease Management 70
5.1 Diagnosis 70
5.2 Treatment Overview 73
5.2.1 Management of Acute Relapse 74
5.2.2 Treatment with Disease-Modifying Therapies 74
5.2.3 Symptomatic Therapies 77
5.3 US 78
5.3.1 Diagnosis 78
5.3.2 Clinical Practice 78
5.4 France 80
5.4.1 Diagnosis 80
5.4.2 Clinical Practice 80
5.5 Germany 82
5.5.1 Diagnosis 82
5.5.2 Clinical Practice 82
5.6 Italy 84
5.6.1 Diagnosis 84
5.6.2 Clinical Practice 84
5.7 Spain 85
5.7.1 Diagnosis 85
5.7.2 Clinical Practice 85
5.8 UK 87
5.8.1 Diagnosis 87
5.8.2 Clinical Practice 87
5.9 Japan 89
5.9.1 Diagnosis 89
5.9.2 Clinical Practice 89
5.10 Canada 90
5.10.1 Diagnosis 90
5.10.2 Clinical Practice 90
5.11 China 91
5.11.1 Diagnosis 91
5.11.2 Clinical Practice 91
5.12 India 92
5.12.1 Diagnosis 92
5.12.2 Clinical Practice 92
6 Competitive Assessment 94
6.1 Overview 94
6.2 Strategic Competitor Assessment 95
6.3 Product Profiles – Major Brands 97
6.3.1 Betaseron/Betaferon (interferon beta-1b) 97
6.3.2 Avonex (interferon beta-1a) 103
6.3.3 Rebif (interferon beta-1a) 109
6.3.4 Copaxone (glatiramer acetate; copolymer-1) 114
6.3.5 Tysabri (natalizumab) 120
6.3.6 Gilenya/Imusera (fingolimod; FTY720) 126
6.3.7 Aubagio (teriflunomide) 132
6.3.8 Other Disease-Modifying Therapies 138
7 Opportunity and Unmet Need 139
7.1 Overview 139
7.2 Unmet Needs 140
7.2.1 Currently Available MS Drugs Only Provide Partial Benefits 140
7.2.2 The High Cost of MS Drugs Could Continue to Price out Patients 141
7.2.3 Safety and Tolerability of Therapy is Undermined by Side Effects 142
7.2.4 Effective Treatments for Progressive MS Are Still Elusive 143
7.2.5 Inconvenient Route of Administration and Frequent Dosing Limits Compliance 144
7.2.6 The Lack of Predictive Biomarkers Delays MS Diagnosis 145
7.3 Unmet Needs Gap Analysis 146
7.4 Opportunities 148
7.4.1 Treatments for Progressive MS 148
7.4.2 Targeting Patients with Clinically Isolated Syndrome 148
8 Pipeline Assessment 149
8.1 Overview 149
8.2 Clinical Trial Mapping 151
8.2.1 Clinical Trials by Country 151
8.3 Clinical Trials by Phase and Trial Status 152
8.4 Promising Drugs in Clinical Development 153
8.4.1 Tecfidera (dimethyl fumarate) 155
8.4.2 Lemtrada (alemtuzumab) 161
8.4.3 Laquinimod (ABR-215062) 168
8.4.4 Daclizumab High-Yield Process (HYP) 175
8.4.5 Ocrelizumab (RG1594) 181
8.4.6 Siponimod (BAF-312) 187
8.4.7 NU-100 (interferon beta-1b) 193
8.4.8 Masitinib (AB-1010) 198
8.4.9 Tcelna (imilecleucel-T) 203
9 Current and Future Players 208
9.1 Overview 208
9.2 Trends in Corporate Strategy 210
9.3 Company Profiles 212
9.3.1 Biogen Idec 212
9.3.2 Teva Pharmaceutical Industries 215
9.3.3 Merck Serono (EMD Serono) 218
9.3.4 Sanofi 221
9.3.5 Bayer HealthCare Pharmaceuticals 224
9.3.6 Novartis International 226
9.3.7 Hoffmann-La Roche 229
9.3.8 GlaxoSmithKline 231
10 Market Outlook 233
10.1 Global Markets 233
10.1.1 Forecast 233
10.1.2 Drivers and Barriers – Global Issues 236
10.2 United States 240
10.2.1 Forecast 240
10.2.2 Key Events 244
10.2.3 Drivers and Barriers 244
10.3 France 247
10.3.1 Forecast 247
10.3.2 Key Events 251
10.3.3 Drivers and Barriers 251
10.4 Germany 254
10.4.1 Forecast 254
10.4.2 Key Events 258
10.4.3 Drivers and Barriers 258
10.5 Italy 261
10.5.1 Forecast 261
10.5.2 Key Events 264
10.5.3 Drivers and Barriers 264
10.6 Spain 267
10.6.1 Forecast 267
10.6.2 Key Events 271
10.6.3 Drivers and Barriers 271
10.7 United Kingdom 273
10.7.1 Forecast 273
10.7.2 Key Events 277
10.7.3 Drivers and Barriers 277
10.8 Japan 280
10.8.1 Forecast 280
10.8.2 Key Events 283
10.8.3 Drivers and Barriers 283
10.9 Canada 285
10.9.1 Forecast 285
10.9.2 Key Events 289
10.9.3 Drivers and Barriers 289
10.10 China 291
10.10.1 Forecast 291
10.10.2 Key Events 294
10.10.3 Drivers and Barriers 295
10.11 India 297
10.11.1 Forecast 297
10.11.2 Key Events 299
10.11.3 Drivers and Barriers 300
11 Appendix 302
11.1 Bibliography 302
11.2 Abbreviations 320
11.3 Methodology 324
11.4 Forecasting Methodology 324
11.4.1 Diagnosed MS patients 324
11.4.2 Percent Drug-Treated Patients 325
11.4.3 Drugs Included in Each Therapeutic Class 325
11.4.4 Launch and Patent Expiry Dates 326
11.4.5 General Pricing Assumptions 327
11.4.6 Individual Drug Assumptions 328
11.4.7 Generic Erosion 332
11.4.8 Pricing of Pipeline agents 332
11.5 Physicians and Specialists Included in This Report 334
11.6 Primary Research – Prescriber Survey 335
11.7 About the Authors 336
11.7.1 Analysts 336
11.7.2 Epidemiologists 337
11.7.3 Global Head of Healthcare 337
11.8 About GlobalData 338
11.9 Contact Us 338
11.10 Disclaimer 338


【レポート販売概要】

■ タイトル:多発性硬化症:世界市場(医薬品市場予測及び分析~2022)
■ 英文:PharmaPoint: Multiple Sclerosis - Global Drug Forecast and Market Analysis to 2022 Event-Driven Update
■ 発行日:2013年4月30日
■ 調査会社:GlobalData
■ 商品コード:GDATA403160899
■ 調査対象地域:グローバル
  • Gaucher’s Disease Type I:グローバル臨床試験動向(2014年上半期)
    Gaucher's Disease Type I Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Gaucher's Disease Type I Global Clinical Trials Review, H1, 2014" provides data on the Gaucher’s Disease Type I clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Gaucher’s Disease Type I. It includes an overview of the trial num …
  • 統合ビル管理システム(IBMS)の世界市場2017-2021
    About Integrated Building Management SystemsThe global IBMS market is expected to record a high growth during the forecast period. Many buildings are expected to opt for integration of their BAS. Integrated systems aid facility managers and building personnel to effectively monitor and regulate operations using a single controller as opposed to individual and distinct controllers for automation so …
  • n‐ブタノールの世界市場
    N-Butanol (CAS 71-36-3) Market Research Report 2013 presents comprehensive data on N-butanol markets globally and regionally (Europe, Asia, North America etc.) The N-Butanol (CAS 71-36-3) Market Research Report 2013 includes N-butanol description, covers its application areas and related patterns. It overviews N-butanol market, names N-butanol producers and indicates its suppliers. Besides, the N- …
  • 世界のポリカーボネート樹脂市場動向及び予測(~2018)
    Polycarbonate is a dominant engineering plastic. It also upholds the image of commodity plastics due to the high consumption and its applicability in a varied range of industries. The PC market experiences strong growth that is expected to get robust in the future. This growth is due to its tremendous physical properties that make it an efficient replacement for traditional plastics and other mate …
  • 鋼(Steel)の世界市場動向2014/2015
    The report presents a thorough study of steel, covering both global and regional markets. It aims to give a proper picture of the market, its trends, perspectives and opportunities. Comprehensive data showing steel worldwide production, consumption, trade statistics and prices are provided. Each country’s market overview covers the following: steel production in the country, major manufacturers, s …
  • 産業用ファイバレーザの世界市場2016-2020
    About Fiber Laser A fiber laser is a different form of solid-state laser that uses a medium of fiber covering instead of a shaft. The fiber in fiber lasers uses more surface area to disperse the heat quite easily. The increasing need for compact components in a variety of industries is bringing lasers into applications. Lasers help in the miniaturization process by providing a highly focused beam …
  • 世界のタンパク成分市場調査レポート:Global Protein Ingredient Market 2014-2018
    TechNavio's analysts forecast the Global Protein Ingredient market to grow at a CAGR of 6.03 percent over the period 2013-2018. One of the key factors contributing to this market growth is the growing global health-conscious population. The Global Protein Ingredient market has also been witnessing the growth in the Food and Beverage industry. However, the low awareness rate could pose a challenge …
  • 閉塞性睡眠時無呼吸(Obstructive Sleep Apnea):世界の治験レビュー2014年下半期版
    Obstructive Sleep Apnea Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Obstructive Sleep Apnea Global Clinical Trials Review, H2, 2014" provides data on the Obstructive Sleep Apnea clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Obstructive Sleep Apnea. It includes an overview of the trial numbers …
  • セイボリー菓子の世界市場2017-2021
    ABSTRACTAbout Savory Snacks Savory snacks come under the snack foods category, which have a salty taste and are different from sweet snacks. The global savory snacks market can be divided into eight major categories: potato chips, extruded snacks, nuts and seeds, frozen potato snacks, ethnic/traditional snacks, popcorn, meat snacks, and other savory snack products. Technavio’s analysts forecast th …
  • 自動車用運転シミュレーター世界市場2017-2021
    ABSTRACTAbout Automotive Driving Simulator Driving simulators, also called as sims, are a class of human-machine interfaces (HMIs), which are used to imitate the exact or near-exact conditions prevalent during driving, with respect to the driver's perspective, motion and physics perspective, as well as the vehicle interior and exterior perspective. Technavio’s analysts forecast the global automoti …
  • 世界の省エネ低馬力ACモーター市場
    The report on global energy efficient low horsepower AC motors market presents an in-depth analysis of the applications, products, and geographic regions of the concerned broad markets for the period from 2013 till 2018. The energy efficient market has been covered under two segments: fractional horsepower AC motors and energy efficient 1hp-3hp AC motors. All the applicationsand geographies that h …
  • PTFEファブリックの世界市場:タイプ別(PTFE被覆ファブリック、不織布、PTFE繊維からなるファブリック)、最終用途産業別(食品、建設、ろ過、その他)、地域別予測
    Global PTFE Fabric Market to reach USD 1028.8 million by 2025. Global PTFE Fabric Market valued approximately USD 630 million in 2016 is anticipated to grow with a healthy growth rate of more than 5.60% over the forecast period 2017-2025. High demand for PTFE fabrics in the automotive industry, their growing consumption in the construction industry, and increasing consumption of composite fabrics …
  • フェノール樹脂の世界市場 :レゾール型フェノール樹脂、ノボラック型フェノール樹脂
    About Phenolic Resins Phenolic resins are synthetic polymers formed by the reaction of phenol and formaldehyde. Phenolic resins have unique physical and chemical properties including high mechanical strength, temperature stability, flame resistance, water and chemical stability, low toxicity, and an excellent performance profile. Owing to their unique properties phenolic resins are used in a wide …
  • バー用業務用冷凍設備の世界市場2018-2022
    About Commercial Bar Refrigeration Equipment Commercial bar refrigeration equipment is used for storing alcoholic beverages at a controlled, required temperature Technavio’s analysts forecast the Global Commercial Bar Refrigeration Equipment to grow at a CAGR of 6.31% during the period 2017-2022. Covered in this report The report covers the present scenario and the growth prospects of the Global C …
  • データセンタ電源ソリューションの世界市場:電源配分及び測定、電源バックアップ、無停電電源装置(UPS)、発電機、ケーブルインフラ
    The global data center power market is expected to be USD 12.30 billion in 2015 and is estimated to grow at a Compound Annual Growth Rate (CAGR) of 10.7% during the forecast period of 2015–2020 and is expected to be USD 20.44 billion in 2020. Enormous growth is seen in the Asia-Pacific (APAC) region and is expected to command the fastest growth within the next 5 years, at a high CAGR of 19.6% by 2 …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。